Amy Althoff is an Infectious Disease physician affiliated with Drexel University. OpenAlex indexes 13 publications with 345 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1427 Vine St
2nd Floor
Philadelphia, PA 191021031
Telephone
215-762-2530Registry record last updated 31 Aug 2016.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ViiV Healthcare CompanyProgram year20242 payments
- Gilead Sciences, Inc.Program year20213 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
34.5%Statin12.5%Atorvastatin Calcium73%Rosuvastatin Calcium27%Part D<11 patientsAngiotensin receptor blocker (ARB)6.6%Losartan Potassium44%Olmesartan Medoxomil26%Losartan-Hydrochlorothiazide17%Valsartan14%Part D<11 patients+ 6 more classes in this area
Nervous system
18%Gabapentinoids5.1%Gabapentin100%Part D≥12 patientsNonsteroidal Anti-inflammatory Drug2.7%Ibuprofen100%Part D<11 patients+ 7 more classes in this area
Metabolism & gastrointestinal
14.8%Proton pump inhibitor7.7%Omeprazole89%Pantoprazole Sodium11%Part D<11 patientsBiguanide (metformin)2.8%Metformin Hcl100%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 65 The Best Tests: Optimizing Detection of Cognitive Decline in People Living with HIV
Journal of the International Neuropsychological Society
2023 - 69 Influence of Cardiovascular Risk Factors on Neuropsychological Trajectories in Black/African American Adults Living with HIV
Journal of the International Neuropsychological Society
2023 - B - 85 Medication Adherence in People Living with HIV: Analyzing Performance-Based Medication Management in Relation to Cognition and Real-World Adherence
Archives of Clinical Neuropsychology
2023 - Brief Report: Financial Incentives and Real-Time Adherence Monitoring to Promote Daily Adherence to HIV Treatment and Viral Suppression Among People Living With HIV: A Pilot Study
JAIDS Journal of Acquired Immune Deficiency Syndromes
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Sataloff, MD
Drexel University
Brett Cucchiara, MD
Drexel University
Daniel Schidlow, MD
Drexel University
Paul Ambrosini, MD
Drexel University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”